Pharmaceuticals & Biotech
Sir Andrew Witty, Chief Executive Officer, GSK

Andrew became Chief Executive Officer of GlaxoSmithKline plc on 21 May 2008. He joined GSK in 1985 and has held a variety of... Read more

Natalie Woodford

Natalie Woodford was appointed SVP, Talent, Leadership & Organisation Development October 2010, running a team with a... Read more

Duncan leads GSK’s Developing Countries and Market Access operating unit. The new group was formed in August 2010 and... Read more

GlaxoSmithKline on

Impact stories

More about GlaxoSmithKline

Click on the links below to view more about this company (please note these link to 3rd party sites):